EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.

Interview Questions:
1. What is the reasoning behind the FLOW Trial?
2. What was the patient population and study design?
3. What are the key results?
4. Were there any surprising or unexpected findings?
5. What further study is needed?

Recorded remotely from Orlando, 2024.